相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The burden of bleeds and other clinical determinants on caregivers of children with haemophilia (the BBC Study)
Kate Khair et al.
HAEMOPHILIA (2019)
Health-related quality of life in children with haemophilia in China: a 4-year follow-up prospective cohort study
Heng Zhang et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2019)
The impact of psychosocial determinants on caregivers' burden of children with haemophilia (results of the BBC study)
Sylvia von Mackensen et al.
HAEMOPHILIA (2019)
From the voices of people with haemophilia A and their caregivers: Challenges with current treatment, their impact on quality of life and desired improvements in future therapies
Ryan E. Wiley et al.
HAEMOPHILIA (2019)
Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII
Susan Kearney et al.
PATIENT PREFERENCE AND ADHERENCE (2019)
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
Guy Young et al.
BLOOD (2019)
Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis
F. Peyvandi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States
J. M. Soucie et al.
HAEMOPHILIA (2017)
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
F. Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Toward optimal therapy for inhibitors in hemophilia
Christine L. Kempton et al.
BLOOD (2014)
Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A
Thierry Calvez et al.
BLOOD (2014)
Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors
S. V. Antunes et al.
HAEMOPHILIA (2014)
Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa
E. Santagostino et al.
HAEMOPHILIA (2014)
Impact of haemophilia with inhibitors on caregiver burden in the United States
M. DeKoven et al.
HAEMOPHILIA (2014)
Health-related Quality of Life in Children and Adolescents With Hemophilia in Basra, Southern Iraq
Murtadha Y. Taha et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2014)
Increased Burden on Caregivers of Having a Child With Haemophilia Complicated by Inhibitors
Karin Lindvall et al.
PEDIATRIC BLOOD & CANCER (2014)
Health-related quality of life in haemophilia patients with inhibitors and their caregivers
M. DeKoven et al.
HAEMOPHILIA (2013)
Factor VIII Products and Inhibitor Development in Severe Hemophilia A
Samantha C. Gouw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
DEVELOPMENT OF AN INHIBITOR-SPECIFIC QUESTIONNAIRE FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN HAEMOPHILIA PATIENTS WITH INHIBITORS (INHIB-QOL)
S. Von Mackensen et al.
VALUE IN HEALTH (2013)
The principal results of the International Immune Tolerance Study: a randomized dose comparison
Charles R. M. Hay et al.
BLOOD (2012)
Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: A critical systematic review
Massimo Franchini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
Takehisa Kitazawa et al.
NATURE MEDICINE (2012)
Burden of Disease Resulting from Hemophilia in the US
Azfar-e-Alam Siddiqi et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2010)
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
E. Santagostino et al.
HAEMOPHILIA (2009)
European Study on Orthopaedic Status of haemophilia patients with inhibitors
M. Morfini et al.
HAEMOPHILIA (2007)
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
B. A. Konkle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Parents of children with haemophilia - a transforming experience
K. Beeton et al.
HAEMOPHILIA (2007)
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors
L Scalone et al.
HAEMOPHILIA (2006)
Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL)
S von Mackensen et al.
HAEMOPHILIA (2004)
Health status and health-related quality of life of children with haemophilia from six West European countries
A Gringeri et al.
HAEMOPHILIA (2004)
A review of measures of quality of life for children with chronic illness
C Eiser et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
分享论文
